|
Market Cap (4-Jul) $617,755,968 (1,200th) |
Close (30-Jun) $0.130 |
Volume (30-Jun) 13,196,801 |
Shortsold (19-Jun) 70,661,833 (3.60%) (67th) |
|
52w High $0.54 |
52w Low $0.283 |
P/E - |
EPS -0.02 |
BOT released this announcement to the ASX on 1 April 2022, 8:11. The announcement is not marked as price sensitive, and is 3 page(s) in length and 207.99kb in size.
You can view all announcements from BOT and see how they appear on a price chart on the announcements page.
At the date of this announcement, BOT was 0.290% short sold according to ASIC data. It was ranked the 377th most shorted stock on the ASX. It is now ranked as the 67th most shorted stock on the ASX with 3.604% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from BOT | |
|---|---|
| Section 708A(5)(e) Notice | 27 June 2023, 19:11 |
| Application for quotation of securities - BOT | 27 June 2023, 19:07 |
| Section 708A(5)(e) Notice | 15 June 2023, 14:07 |
| Experienced dermatology executives join Botanix | 1 April 2022, 8:11 |
| Botanix receives $2.75m R&D Tax Incentive Refund | 28 March 2022, 8:22 |
| Botanix to present at Switzer Virtual Investor Day | 22 March 2022, 18:55 |
| Change of Director's Interest Notice DS | 22 March 2022, 18:44 |
You must be logged in to post a reply.
Botanix Pharmaceuticals 